Original Research

Published on 15 Nov 2021

Dihydromyricetin Reverses Thioacetamide-Induced Liver Fibrosis Through Inhibiting NF-κB-Mediated Inflammation and TGF-β1-Regulated of PI3K/Akt Signaling Pathway

in Gastrointestinal and Hepatic Pharmacology

Yingchun Zhao
Xinglong Liu
Chuanbo Ding
Yan Gu
Wencong Liu

Frontiers in Pharmacology

doi 10.3389/fphar.2021.783886

5,926 views
36 citations

Original Research

Published on 11 Nov 2021

The Protective Effect of Panax notoginseng Mixture on Hepatic Ischemia/Reperfusion Injury in Mice via Regulating NR3C2, SRC, and GAPDH

in Gastrointestinal and Hepatic Pharmacology

Wen Hou
Bao Wei
Hong Sheng Liu

Frontiers in Pharmacology

doi 10.3389/fphar.2021.756259

3,169 views
4 citations

Original Research

Published on 11 Nov 2021

Elevated Serum Uric Acid is Associated With Poor Survival in Advanced HCC Patients and Febuxostat Improves Prognosis in HCC Rats

in Gastrointestinal and Hepatic Pharmacology

Le Wu
Wenlong Yang
Yu Zhang
Xiaoyue Du
Nan Jin
Wen Chen
Huangbao Li
Shouhua Zhang
Baogang Xie

Frontiers in Pharmacology

doi 10.3389/fphar.2021.778890

3,722 views
7 citations

Original Research

Published on 08 Nov 2021

An Investigation of the Risk Factors Associated With Anti-Tuberculosis Drug-Induced Liver Injury or Abnormal Liver Functioning in 757 Patients With Pulmonary Tuberculosis

in Gastrointestinal and Hepatic Pharmacology

Tao Zhong
Yuzheng Fan
Xiao-Li Dong
Xujun Guo
Ka Hing Wong
Wing-tak Wong
Daihai He
Shengyuan Liu

Frontiers in Pharmacology

doi 10.3389/fphar.2021.708522

4,957 views
18 citations

Review

Published on 08 Nov 2021

The Pathological Mechanisms of Estrogen-Induced Cholestasis: Current Perspectives

in Gastrointestinal and Hepatic Pharmacology

Yue Zu
Jinyu Yang
Chengliang Zhang
Dong Liu

Frontiers in Pharmacology

doi 10.3389/fphar.2021.761255

14,299 views
27 citations

Review

Published on 04 Nov 2021

The Potential Application of Chinese Medicine in Liver Diseases: A New Opportunity

in Gastrointestinal and Hepatic Pharmacology

Ke Fu
Cheng Wang
Cheng Ma
Honglin Zhou
Yunxia Li

Frontiers in Pharmacology

doi 10.3389/fphar.2021.771459

11,222 views
26 citations

Mini Review

Published on 04 Nov 2021

Potential Role for Combined Subtype-Selective Targeting of M1 and M3 Muscarinic Receptors in Gastrointestinal and Liver Diseases

in Gastrointestinal and Hepatic Pharmacology

Mazen Tolaymat
Margaret H. Sundel
Madeline Alizadeh
Guofeng Xie
Jean-Pierre Raufman

Frontiers in Pharmacology

doi 10.3389/fphar.2021.786105

5,448 views
11 citations

Systematic Review

Published on 03 Nov 2021

The Effects of Vitamin D Supplementation on Anthropometric and Biochemical Indices in Patients With Non-alcoholic Fatty Liver Disease: A Systematic Review and Meta-analysis

in Gastrointestinal and Hepatic Pharmacology

Shahla Rezaei
Reza Tabrizi
Peyman Nowrouzi-Sohrabi
Mohammad Jalali
Mojtaba Shabani-Borujeni
Shayan Modaresi
Maryam Gholamalizadeh
Saeid Doaei

Frontiers in Pharmacology

doi 10.3389/fphar.2021.732496

28,300 views
21 citations

Original Research

Published on 02 Nov 2021

Real-World Data of Tigecycline-Associated Drug-Induced Liver Injury Among Patients in China: A 3-year Retrospective Study as Assessed by the Updated RUCAM

in Gastrointestinal and Hepatic Pharmacology

Xiaoping Shi
Chengchun Zuo
Lingling Yu
Donghui Lao
Xiaoyu Li
Qing Xu
Qianzhou Lv

Frontiers in Pharmacology

doi 10.3389/fphar.2021.761167

4,718 views
15 citations

Original Research

Published on 02 Nov 2021

Berberine Improves Irinotecan-Induced Intestinal Mucositis Without Impairing the Anti-colorectal Cancer Efficacy of Irinotecan by Inhibiting Bacterial β-glucuronidase

in Gastrointestinal and Hepatic Pharmacology

Bei Yue
Ruiyang Gao
Cheng Lv
Zhilun Yu
Hao Wang
Xiaolong Geng
Zhengtao Wang
Wei Dou

Frontiers in Pharmacology

doi 10.3389/fphar.2021.774560

5,143 views
22 citations

Original Research

Published on 01 Nov 2021

Therapeutic Suppression of FAK-AKT Signaling Overcomes Resistance to SHP2 Inhibition in Colorectal Carcinoma

in Gastrointestinal and Hepatic Pharmacology

Ye Li
Yuncang Yuan
Fan Zhang
Aizhen Guo
Fuao Cao
Mengmeng Song
Yating Fu
Xiaowen Xu
Hao Shen
Shangyong Zheng

Frontiers in Pharmacology

doi 10.3389/fphar.2021.739501

4,083 views
6 citations

Mini Review

Published on 29 Oct 2021

Curcuma longa Hepatotoxicity: A Baseless Accusation. Cases Assessed for Causality Using RUCAM Method

in Gastrointestinal and Hepatic Pharmacology

Gianmarco Stati
Francesco Rossi
Silvia Sancilio
Mariangela Basile
Roberta Di Pietro

Frontiers in Pharmacology

doi 10.3389/fphar.2021.780330

8,583 views
14 citations

Systematic Review

Published on 27 Oct 2021

Role of Ursodeoxycholic Acid in Treating and Preventing Idiosyncratic Drug-Induced Liver Injury. A Systematic Review

in Gastrointestinal and Hepatic Pharmacology

Mercedes Robles-Díaz
Lana Nezic
Vesna Vujic-Aleksic
Einar S. Björnsson

Frontiers in Pharmacology

doi 10.3389/fphar.2021.744488

13,622 views
25 citations

Mini Review

Published on 20 Oct 2021

Inflammatory Bowel Disease and Risk of Colorectal Cancer: An Overview From Pathophysiology to Pharmacological Prevention

in Gastrointestinal and Hepatic Pharmacology

Marianna Lucafò
Debora Curci
Martina Franzin
Giuliana Decorti
Gabriele Stocco

Frontiers in Pharmacology

doi 10.3389/fphar.2021.772101

16,215 views
71 citations

Original Research

Published on 20 Oct 2021

Non-Invasive Remote Ischemic Preconditioning May Protect the Gastric Mucosa Against Ischemia-Reperfusion-Induced Injury Through Involvement of Glucocorticoids

in Gastrointestinal and Hepatic Pharmacology

Ludmila Filaretova
Olga Komkova
Maria Sudalina
Natalia Yarushkina

Frontiers in Pharmacology

doi 10.3389/fphar.2021.682643

1,891 views
12 citations

Systematic Review

Published on 15 Oct 2021

Influence of Cytochrome P450 2C19 Genotype on Helicobacter pylori Proton Pump Inhibitor-Amoxicillin-Clarithromycin Eradication Therapy: A Meta-Analysis

in Gastrointestinal and Hepatic Pharmacology

Yuko Morino
Mitsushige Sugimoto
Naoyoshi Nagata
Ryota Niikiura
Eri Iwata
Mariko Hamada
Yusuke Kawai
Tatsuhiro Fujimiya
Hironori Takeuchi
Sakae Unezaki

Frontiers in Pharmacology

doi 10.3389/fphar.2021.759249

5,181 views
18 citations

Navigation group

Articles

Dihydromyricetin Reverses Thioacetamide-Induced Liver Fibrosis Through Inhibiting NF-κB-Mediated Inflammation and TGF-β1-Regulated of PI3K/Akt Signaling Pathway

The Protective Effect of Panax notoginseng Mixture on Hepatic Ischemia/Reperfusion Injury in Mice via Regulating NR3C2, SRC, and GAPDH

Elevated Serum Uric Acid is Associated With Poor Survival in Advanced HCC Patients and Febuxostat Improves Prognosis in HCC Rats

An Investigation of the Risk Factors Associated With Anti-Tuberculosis Drug-Induced Liver Injury or Abnormal Liver Functioning in 757 Patients With Pulmonary Tuberculosis

The Pathological Mechanisms of Estrogen-Induced Cholestasis: Current Perspectives

The Potential Application of Chinese Medicine in Liver Diseases: A New Opportunity

Potential Role for Combined Subtype-Selective Targeting of M1 and M3 Muscarinic Receptors in Gastrointestinal and Liver Diseases

The Effects of Vitamin D Supplementation on Anthropometric and Biochemical Indices in Patients With Non-alcoholic Fatty Liver Disease: A Systematic Review and Meta-analysis

Real-World Data of Tigecycline-Associated Drug-Induced Liver Injury Among Patients in China: A 3-year Retrospective Study as Assessed by the Updated RUCAM

Berberine Improves Irinotecan-Induced Intestinal Mucositis Without Impairing the Anti-colorectal Cancer Efficacy of Irinotecan by Inhibiting Bacterial β-glucuronidase

Therapeutic Suppression of FAK-AKT Signaling Overcomes Resistance to SHP2 Inhibition in Colorectal Carcinoma

Curcuma longa Hepatotoxicity: A Baseless Accusation. Cases Assessed for Causality Using RUCAM Method

Role of Ursodeoxycholic Acid in Treating and Preventing Idiosyncratic Drug-Induced Liver Injury. A Systematic Review

Inflammatory Bowel Disease and Risk of Colorectal Cancer: An Overview From Pathophysiology to Pharmacological Prevention

Non-Invasive Remote Ischemic Preconditioning May Protect the Gastric Mucosa Against Ischemia-Reperfusion-Induced Injury Through Involvement of Glucocorticoids

Influence of Cytochrome P450 2C19 Genotype on Helicobacter pylori Proton Pump Inhibitor-Amoxicillin-Clarithromycin Eradication Therapy: A Meta-Analysis